Health and Me

Tanya Dutt

Influenza Raises Heart Attack Risk By 6X– Here's Another Reason To Get Your Flu Shot

Influenza Raises Heart Attack Risk By 6X – Here's Another Reason To Get Your Flu Shot

Each year, millions brace for the <span>flu season</span>, armed with cough drops, hand sanitizers, and the age-old debate- should I get the <span>flu</span> shot? While many associate <span><a href="https://www.healthandme.com/health/influenza">influenza</a></span> with little more than a fever and fatigue, mounting research suggests the consequences could be far more severe. A new study has added a significant warning to the mix: contracting the flu could increase your risk of a heart attack by six times in the week following infection.

A heart attack, or myocardial infarction, occurs when blood flow to the heart muscle is abruptly cut off, often due to a blood clot. While risk factors like smoking, high cholesterol, and obesity are well-known contributors, seasonal influenza now emerges as a stealthy but significant trigger, particularly in those already vulnerable.

This link isn't new. For years, scientists have warned that viral infections can increase cardiovascular risk. However, this latest data provides one of the clearest pictures yet. Researchers evaluated 401 patients who had a heart attack within a year before or after a confirmed flu diagnosis. Alarmingly, 25 heart attacks occurred in the first seven days following influenza infection.

<h2>How Influenza Triggers Heart Conditions?</h2>

Influenza does more than inflame the lungs — it can inflame the arteries, too. When the virus attacks, the immune system responds with inflammation. In people with existing plaque buildup in their arteries, this inflammation can weaken plaque stability, making it more likely to rupture. Once ruptured, the body reacts with clot formation, blocking blood flow and causing a heart attack.

In some cases, the flu virus may also increase blood coagulation, further raising the risk of clot formation. “When people get influenza or the flu, it taxes your body and puts a lot of stress on all of the other systems,” explains Dr. Susan Rehm, an infectious disease specialist at the Cleveland Clinic.

The study, led by Dr. Annemarijn de Boer and conducted using data from 16 diagnostic labs across The Netherlands, confirms what many health professionals have long suspected. It found that patients who suffered a heart attack after getting the flu were at significantly higher risk of mortality with 35% dying within a year of their flu diagnosis.

“While it isn’t clear from our results if those with less severe flu are also at risk, it is prudent for them to be aware of the link,” Dr. de Boer notes. The findings will be presented at the European Congress of Clinical Microbiology and Infectious Diseases.

<h2>How Can A Flu Shot Protect Against Potent Cardiac Condition?</h2>

Perhaps the most actionable takeaway from this research is simple- get your flu shot. For years, influenza vaccination has been recommended primarily for its ability to reduce flu-related complications, especially among vulnerable populations like the elderly, children, and those with chronic conditions.

Now, cardiologists and infectious disease experts are urging people especially those with cardiovascular conditions to think of the flu vaccine as an indirect heart attack prevention tool.

A study conducted by the Glasgow Institute of Cardiovascular and Medical Sciences found that heart attack patients who received the flu vaccine within 72 hours of their first event had a 50% lower risk of death from a subsequent heart attack. “Flu puts stress on your arteries and makes your blood thicker, so if you have heart disease, it could tip you over the threshold,” said Professor Naveed Sattar of the Institute.

The data is clear: flu shots save more than just lungs — they may save hearts. Consultant cardiologist Professor Martin Cowie of the Royal Brompton Hospital supports this proactive approach. “This is interesting and could be relatively easy to implement in general practice,” he notes. With flu vaccine supplies already stocked by national health systems, including the NHS, implementing flu shots as part of post-heart attack care could be done swiftly and effectively.

While influenza vaccination is a crucial tool, long-term heart health requires broader lifestyle changes. Coronary heart disease is the most common cause of heart attacks is primarily driven by modifiable risk factors: high-fat diets, inactivity, smoking, high blood pressure, and obesity.

One form of preventive care gaining renewed interest is cycling. A recent study published in the journal Sports Medicine found that individuals who cycle regularly especially for commuting or errands were 23% less likely to die prematurely. Just 130 minutes of cycling per week can significantly reduce the risk of cardiovascular disease.

As flu season approaches, getting vaccinated should be considered not just a personal choice but a cardiovascular strategy. The six-fold increase in heart attack risk following influenza infection is a sobering statistic — especially for those already living with heart disease.

Health Conditions A-Z

health

influenza

flu season

influenza statistics 2024

cdc flu report

flu hospitalizations 2025

pediatric flu deaths

flu vaccine effectiveness

global influenza trend

COVID Cases Rise In US, Trump Administration To Alter Vaccine Policy

Rise In Drug-Related Deaths Blamed For Increase In UK Mortality Rate

About 2 Out Of 5 Heart Failure Patients Don’t See A Cardiologist Even Once A Year

Health News

Why Does Sleeping Become Harder As You Age?

High-Fiber Healthy Drinks You Should Try

10 Dumbbell Exercise Variations For Upper-Body Strength

A Parent’s Guide To Pets: Important Points To Consider For Your Child’s Health

Food Anxiety Is Real – How Your Food Intake Affects Your Anxiety

World Osteoporosis Month: Ways To Strengthen Your Bones

Brain Exercises To Keep You Cognitively Sharp

Easy Recipes To Make When You Don’t Wish To Cook

Physical Signs Of High Cortisol

9 Healthy Plant-Based Protein Rich Dishes To Try

What Happens When You Have Low Blood Pressure?

Throw These Toxic Bathroom Items Away To Protect Your Health

This Is What Cricket Superstar Virat Kohli Eats In A Day

Signs You Are Experiencing Sensory Overload

Shoulder Exercises You Should Do For Defined Shoulders

Best Foods To Eat When You Are Fasting

​Ghee For Ayurveda: Why It Should Be A Part Of Your Diet​

Symptoms Of Ovarian Cancer You Should Know

Yoga Poses That Can Build Core Strength

Biotin-Rich Foods You Should Add To Your Diet

Unexpected Physical Signs Of Stress

Simple And Affective Guide To Stop A Panic Attack

Signs Of Heat Exhaustion In Children

10 Heart Symptoms You Shouldn't Ignore

Lower Your Cholesterol With These Foods

Food Myths You Should Stop Believing

Work Stressing You Out? Tips To Handle Toxic Workspaces

Looking To Gain Weight? High-Calorie Healthy Foods To Try

​Pomegranates Are A Must For Summer, Here’s Why​

​How Does Being A Night Owl Change Your Brain​

​Can Nightlights Affect Your Child’s Sleep​

How To Decide Whether You Should Do Cardio Or Strength Training?

Enjoying Hobbies As An Adult Is More Important Than You Realize

Screentime Matters For Parents Too, Here's How It Causes Issues

Why Should We Discard Expired Prescription Drugs?

Perks Of Having Home Plants For Your Health

Signs You Are Dealing With Depleted Mother Syndrome

Protein-Rich Fruit Smoothies You Must Try

Ways You Can Reach Out To Someone In A Mental Health Crisis

These Things Are Causing You To Lose Sleep

Each year, millions brace for the flu season, armed with cough drops, hand sanitizers, and the age-old debate- should I get the flu shot? While many associate influenza with little more than a fever and fatigue, mounting research suggests the consequences could be far more severe. A new study has added a significant warning to the mix: contracting the flu could increase your risk of a heart attack by six times in the week following infection.A heart attack, or myocardial infarction, occurs when blood flow to the heart muscle is abruptly cut off, often due to a blood clot. While risk factors like smoking, high cholesterol, and obesity are well-known contributors, seasonal influenza now emerges as a stealthy but significant trigger, particularly in those already vulnerable.This link isn't new. For years, scientists have warned that viral infections can increase cardiovascular risk. However, this latest data provides one of the clearest pictures yet. Researchers evaluated 401 patients who had a heart attack within a year before or after a confirmed flu diagnosis. Alarmingly, 25 heart attacks occurred in the first seven days following influenza infection.How Influenza Triggers Heart Conditions?Influenza does more than inflame the lungs — it can inflame the arteries, too. When the virus attacks, the immune system responds with inflammation. In people with existing plaque buildup in their arteries, this inflammation can weaken plaque stability, making it more likely to rupture. Once ruptured, the body reacts with clot formation, blocking blood flow and causing a heart attack.In some cases, the flu virus may also increase blood coagulation, further raising the risk of clot formation. “When people get influenza or the flu, it taxes your body and puts a lot of stress on all of the other systems,” explains Dr. Susan Rehm, an infectious disease specialist at the Cleveland Clinic.The study, led by Dr. Annemarijn de Boer and conducted using data from 16 diagnostic labs across The Netherlands, confirms what many health professionals have long suspected. It found that patients who suffered a heart attack after getting the flu were at significantly higher risk of mortality with 35% dying within a year of their flu diagnosis.“While it isn’t clear from our results if those with less severe flu are also at risk, it is prudent for them to be aware of the link,” Dr. de Boer notes. The findings will be presented at the European Congress of Clinical Microbiology and Infectious Diseases.How Can A Flu Shot Protect Against Potent Cardiac Condition?Perhaps the most actionable takeaway from this research is simple- get your flu shot. For years, influenza vaccination has been recommended primarily for its ability to reduce flu-related complications, especially among vulnerable populations like the elderly, children, and those with chronic conditions.Now, cardiologists and infectious disease experts are urging people especially those with cardiovascular conditions to think of the flu vaccine as an indirect heart attack prevention tool.A study conducted by the Glasgow Institute of Cardiovascular and Medical Sciences found that heart attack patients who received the flu vaccine within 72 hours of their first event had a 50% lower risk of death from a subsequent heart attack. “Flu puts stress on your arteries and makes your blood thicker, so if you have heart disease, it could tip you over the threshold,” said Professor Naveed Sattar of the Institute.The data is clear: flu shots save more than just lungs — they may save hearts. Consultant cardiologist Professor Martin Cowie of the Royal Brompton Hospital supports this proactive approach. “This is interesting and could be relatively easy to implement in general practice,” he notes. With flu vaccine supplies already stocked by national health systems, including the NHS, implementing flu shots as part of post-heart attack care could be done swiftly and effectively.Long-Term Heart HealthWhile influenza vaccination is a crucial tool, long-term heart health requires broader lifestyle changes. Coronary heart disease is the most common cause of heart attacks is primarily driven by modifiable risk factors: high-fat diets, inactivity, smoking, high blood pressure, and obesity.One form of preventive care gaining renewed interest is cycling. A recent study published in the journal Sports Medicine found that individuals who cycle regularly especially for commuting or errands were 23% less likely to die prematurely. Just 130 minutes of cycling per week can significantly reduce the risk of cardiovascular disease.As flu season approaches, getting vaccinated should be considered not just a personal choice but a cardiovascular strategy. The six-fold increase in heart attack risk following influenza infection is a sobering statistic — especially for those already living with heart disease.

influenza raises heart attack risk by 6x– here's another reason to get your flu shot

Riya Baibhawi

FDA Approves New COVID Vaccine But Not Everyone Qualifies

fda approves new covid vaccine but not everyone qualifies

Health & Wellness

First-Ever Acne Vaccine Enters Clinical Trials; Could Clear Skin Be Just One Shot Away?

first-ever acne vaccine enters clinical trials; could clear skin be just one shot away?

Covid Cases Surge In Singapore: What Do We Know About The New Variant On The Loose?

covid cases surge in singapore: what do we know about the new variant on the loose?

US administration is slated to lay out a new approach to COVID vaccination at an event on Tuesday that could spell major changes in what is required to get regulatory approval for immunisations. The US Food and Drug Administration (FDA) is featuring an upcoming town hall, set to begin Tuesday at 1 pm in Washington, titled "An evidence based approach to Covid vaccination." The two speakers listed are FDA Commissioner Marty Makary and Vinay Prasad, an outspoken critic of the drug industry who was recently appointed to lead the agency’s division that oversees vaccines. 

This comes as the U.S. The Health and Human Services Department says it will require placebo testing of “all new vaccines.” In a statement to the Washington Post, the agency headed by Robert F. Kennedy Jr. called the new requirement “a radical departure from past practices.” It must be noted that Kennedy Jr. has been a blatant vaxxer.

Why is Covid Vaccination Still Important?

In contrast to the mRNA-based platforms of Pfizer-BioNTech and Moderna, Novavax's vaccine is based on a recombinant protein platform—a technology that is akin to those employed in licensed vaccines such as hepatitis B. This technology could be desirable to those who were resistant to mRNA vaccines because they are worried about newer biotechnology.

Experts indicate that the Novavax vaccine might also be attractive in populations or regions where cold storage demands for mRNA vaccines have presented logistical problems. Yet with limited approval, this advantage won't necessarily come into full play under the existing rollout.

Who Can Actually Get The New Covid Vaccine?

The newly approved Novavax vaccine under the brand name Nuvaxovid will only be issued to:

People aged 12 to 64 years with underlying health conditions

Such conditions, according to the Centers for Disease Control and Prevention (CDC), include asthma, diabetes, obesity, cardiovascular disease, and pregnancy. Behavioral and lifestyle risks like smoking, physical inactivity, and substance abuse also come under this category.

While the wide range of risk factors might limit the decision to many, most in the medical field find the ruling too restrictive. Former FDA Chief Scientist Jesse Goodman criticized the agency's limited approval publicly, saying, "The FDA approval process is intended to determine safety and efficacy, and permit access to approved vaccines. It is not where one makes policy suggestions for use of approved vaccines." 

COVID-19

Coronavirus

coronavirus vaccine

robert f kennedy jr

covid vaccines

US administration is slated to lay out a new approach to COVID vaccination at an event on Tuesday that could spell major changes in what is required to get regulatory approval for immunisations. The US Food and Drug Administration (FDA) is featuring an upcoming town hall, set to begin Tuesday at 1 pm in Washington, titled "An evidence based approach to Covid vaccination." The two speakers listed are FDA Commissioner Marty Makary and Vinay Prasad, an outspoken critic of the drug industry who was recently appointed to lead the agency’s division that oversees vaccines. This comes as the U.S. The Health and Human Services Department says it will require placebo testing of “all new vaccines.” In a statement to the Washington Post, the agency headed by Robert F. Kennedy Jr. called the new requirement “a radical departure from past practices.” It must be noted that Kennedy Jr. has been a blatant vaxxer.Why is Covid Vaccination Still Important?In contrast to the mRNA-based platforms of Pfizer-BioNTech and Moderna, Novavax's vaccine is based on a recombinant protein platform—a technology that is akin to those employed in licensed vaccines such as hepatitis B. This technology could be desirable to those who were resistant to mRNA vaccines because they are worried about newer biotechnology.Experts indicate that the Novavax vaccine might also be attractive in populations or regions where cold storage demands for mRNA vaccines have presented logistical problems. Yet with limited approval, this advantage won't necessarily come into full play under the existing rollout.Who Can Actually Get The New Covid Vaccine?The newly approved Novavax vaccine under the brand name Nuvaxovid will only be issued to:Adults 65 and olderPeople aged 12 to 64 years with underlying health conditionsSuch conditions, according to the Centers for Disease Control and Prevention (CDC), include asthma, diabetes, obesity, cardiovascular disease, and pregnancy. Behavioral and lifestyle risks like smoking, physical inactivity, and substance abuse also come under this category.While the wide range of risk factors might limit the decision to many, most in the medical field find the ruling too restrictive. Former FDA Chief Scientist Jesse Goodman criticized the agency's limited approval publicly, saying, "The FDA approval process is intended to determine safety and efficacy, and permit access to approved vaccines. It is not where one makes policy suggestions for use of approved vaccines." 

covid cases rise in us, trump administration to alter vaccine policy

Nutrition

High Cholesterol Linked To Longer Life Spans In This Blue Zone

high cholesterol linked to longer life spans in this blue zone

about 2 out of 5 heart failure patients don’t see a cardiologist even once a year

Ozempic Without The Side Effects? Try This Drug-Free Method

ozempic without the side effects? try this drug-free method

The newly-released figures show a troubling trend in death rates in the UK when compared with 21 other high-income countries, as well as finding deep inequalities in health between different parts of the UK.

Drawing on new research commissioned from the London School of Hygiene &amp; Tropical Medicine, the data suggest improvements in UK death rates slowed down significantly in the 2010s, more so than in most of the 21 other high-income countries studied.

By 2023, female mortality rates in the UK were 14% higher than the median of peer countries, with male mortality rates 9% higher. The research reveals significant inequalities across the UK.

Scotland, Wales and Northern Ireland all have higher <span>mortality rate</span>s than England, with Scotland performing particularly poorly. In 2021, only the US had a worse mortality rate than Scotland among the countries studied, while mortality rates were 20% higher in the North East and North West of England than in the South West.

Read more: Russia and Ukraine to 'immediately' start ceasefire talks as Zelenskyy pitches ‘high-level’ meeting of world leaders

The relative worsening of death rates among the working age population is particularly stark. In 2023, female mortality rates for people aged 25-49 were 46% higher than the median of the other countries studied, and male rates were 31% higher.

Only Canada and the US experienced a similar worsening of death rates among this age group during the 2010s.

Poorer working age health in the UK is leading to lower labour force participation and acting as a drag on growth. Among the top three causes of death for people aged 25–49, death rates for cancers and circulatory diseases improved between 2001 and 2019.

In contrast, death rates from external causes (deaths due to injuries, poisonings and violence) worsened, accounting for 70%-80% of the difference in UK death rates at this age compared to the median of the countries studied over this period.

The research found that this is being fuelled by a shocking rise in drug-related deaths, with the rate of drug-related deaths in the UK more than three times higher in 2019 than the average of peer countries. It also found stark geographic inequalities in drug-related deaths.

In 2019, the drug-related mortality rate among 25–49-year-olds in Scotland was around 4 times higher than in England. Within England, the drug-related mortality rate in the North East was 3.5 times higher for males and almost 4 times higher for females than in London.

With the UK's health comparing increasingly poorly with other high-income countries, the Health Foundation is calling for a new strategy to tackle health inequalities, alongside long-term action to rebuild the nation's health and promote economic recovery in areas of long run industrial decline.

Dame Jennifer Dixon, Chief Executive of the Health Foundation, said: “This report is a health check we can’t afford to ignore – and the diagnosis is grim.

"The UK is becoming the sick person of the wealthy world, especially for people of working age. While other nations moved forward, we stalled – and in some areas, slipped badly behind."

The soaring drug-related deaths in Scotland and the North East are not just tragic – they are symptoms of long-standing neglect, economic stagnation and policy failure.

It’s clear that sticking plasters won’t cut it: we need a bold, long-term health strategy that tackles prevention, inequality, and underinvestment in public health head-on. And in particular far more urgent and targeted action on drugs.

“Improvements are possible and urgently needed Improving the nation’s health is not a luxury – it’s a necessity for economic growth and social stability.”

uk health news

Mortality rate

UK Health

Drug addiction

Drug related deaths

The newly-released figures show a troubling trend in death rates in the UK when compared with 21 other high-income countries, as well as finding deep inequalities in health between different parts of the UK.Drawing on new research commissioned from the London School of Hygiene & Tropical Medicine, the data suggest improvements in UK death rates slowed down significantly in the 2010s, more so than in most of the 21 other high-income countries studied.By 2023, female mortality rates in the UK were 14% higher than the median of peer countries, with male mortality rates 9% higher. The research reveals significant inequalities across the UK.Scotland, Wales and Northern Ireland all have higher mortality rates than England, with Scotland performing particularly poorly. In 2021, only the US had a worse mortality rate than Scotland among the countries studied, while mortality rates were 20% higher in the North East and North West of England than in the South West.Read more: Russia and Ukraine to 'immediately' start ceasefire talks as Zelenskyy pitches ‘high-level’ meeting of world leadersThe relative worsening of death rates among the working age population is particularly stark. In 2023, female mortality rates for people aged 25-49 were 46% higher than the median of the other countries studied, and male rates were 31% higher.Only Canada and the US experienced a similar worsening of death rates among this age group during the 2010s.Poorer working age health in the UK is leading to lower labour force participation and acting as a drag on growth. Among the top three causes of death for people aged 25–49, death rates for cancers and circulatory diseases improved between 2001 and 2019.In contrast, death rates from external causes (deaths due to injuries, poisonings and violence) worsened, accounting for 70%-80% of the difference in UK death rates at this age compared to the median of the countries studied over this period.The research found that this is being fuelled by a shocking rise in drug-related deaths, with the rate of drug-related deaths in the UK more than three times higher in 2019 than the average of peer countries. It also found stark geographic inequalities in drug-related deaths.In 2019, the drug-related mortality rate among 25–49-year-olds in Scotland was around 4 times higher than in England. Within England, the drug-related mortality rate in the North East was 3.5 times higher for males and almost 4 times higher for females than in London.With the UK's health comparing increasingly poorly with other high-income countries, the Health Foundation is calling for a new strategy to tackle health inequalities, alongside long-term action to rebuild the nation's health and promote economic recovery in areas of long run industrial decline.Dame Jennifer Dixon, Chief Executive of the Health Foundation, said: “This report is a health check we can’t afford to ignore – and the diagnosis is grim."The UK is becoming the sick person of the wealthy world, especially for people of working age. While other nations moved forward, we stalled – and in some areas, slipped badly behind."The soaring drug-related deaths in Scotland and the North East are not just tragic – they are symptoms of long-standing neglect, economic stagnation and policy failure.It’s clear that sticking plasters won’t cut it: we need a bold, long-term health strategy that tackles prevention, inequality, and underinvestment in public health head-on. And in particular far more urgent and targeted action on drugs.“Improvements are possible and urgently needed Improving the nation’s health is not a luxury – it’s a necessity for economic growth and social stability.”

rise in drug-related deaths blamed for increase in uk mortality rate

Longest Covid Infection Reported Lasted 505 Days Nonstop; What Are Persistent Infections?

Longest Covid Infection Reported Lasted 505 Days Nonstop

This Super-Fit Non-Smoker Mom, 34, Diagnosed With Incurable Lung Cancer- Mistook Symptom For Gym Injury

this super-fit non-smoker mom, 34, diagnosed with incurable lung cancer- mistook symptom for gym injury

Can you imagine testing positive for <span>COVID-19</span> for more than 500 days- during lockdowns, vaccine distributions, new strains, and changing worldwide policies? It reads like the script of a dystopian thriller, but it's real and illustrates just how capricious this virus has proven to be, five years on from its initial outbreak.

As we step through 2025 with vaccines out there in plenty, rapid testing business as usual, and public health measures optimized, it's hard not to consider COVID-19 a chapter we're finally closing. But for a number of people, the virus wasn't an ordeal that lasted for a matter of weeks, but a long, persistent fight. One such example in the United Kingdom beat all known records: a man was infected with the virus for an incredible 505 days before his death, which stands as the longest confirmed <span>COVID-19 infection</span> to date.

British researchers have found what seems to be the longest-reported COVID-19 infection to date, an astonishing 505 days. The case of the unnamed patient with several chronic health conditions and a very compromised immune system highlights the nuance of how SARS-CoV-2 acts in immunocompromised patients.

The patient, who had tested positive for COVID-19 early in the year 2020, was infected for the rest of their life until they passed away in 2021 despite treatment interventions such as antiviral medication. This case has redefined what the global medical community knows about persistent COVID-19 infections and presented new avenues for research and better care for at-risk populations.

<h2>What Makes This Case And Persistent COVID-19 Different?</h2>

One of the most important differences to grasp is between "persistent" infection from COVID-19 and "Long COVID." While Long COVID is a term used for symptoms that persist after the virus has cleared from the body, persistent infection involves ongoing viral replication over time. The virus in this instance never actually leaves the body, which forms ongoing active infection instead of residual symptoms.

In this British case, all of the patient's over 50 PCR tests in 72 weeks returned positive, indicating a persistent, constant infection. This was reinforced by King's College London and Guy's and St Thomas' NHS Foundation Trust researchers through genomic sequencing that indicated it was the same strain evolving over time—not repeated reinfections.

This unusual case was one of many included in a larger study that was discussed at the European Congress of Clinical Microbiology and Infectious Diseases by infectious disease specialist Dr. Luke Blagdon Snell. The study looked at nine patients with long-term infections, all lasting at least eight weeks. These patients, whose immune systems were severely impaired due to illness such as HIV, cancer, or immunosuppressive drugs used after organ transplant, provided an unusual insight into what happens when the body is unable to respond with a normal immune response.

The typical length of infection in the nine patients was about 73 days. Prior to the identification of this record case, the longest-documented COVID-19 infection was 335 days long.

While unusual, these long-term infections create worries beyond the patients themselves. One of the scientists' biggest worries is that the virus, not having been contained by the body for so long, could mutate into new strains. Though none of the patients in this case—including one who had a 505-day infection—gave rise to a new variant of concern, genetic analysis did reveal mutations like those that occur in highly circulated variants.

"This doesn't say anything about a single patient. It says something about how the virus might evolve over time if left in a setting in which it's not eliminated," Dr. Snell stated.

Even after receiving antiviral medications such as remdesivir, the patient could not eliminate the infection, showing the insufficiency of existing treatments in certain high-risk groups. Among the nine patients analyzed, five survived with different recovery trajectories. Two cleared the virus without any medication, two were responsive to antiviral treatment, and one patient remained infected after 412 days at the last reported follow-up.

This unsettling volatility identifies the imperative for greater treatment options and care customization for immunocompromised individuals.

<h2>What This Means for People With Low Immunity?</h2>

Tens of millions of individuals across the globe have weakened immune systems—because of organ transplants, autoimmune conditions, or cancer treatments. The results from this study indicate an immediate call to maintain awareness in safeguarding these groups, particularly as pandemic measures loosened and mask mandates are all but gone.

This case not only illuminates the biological dynamics of COVID-19 but also serves as a reminder of the human narratives behind pandemic statistics. This patient existed, in a state of health most people shake off in a matter of days or weeks, for almost a year and a half—a grim reminder of the unpredictability of the virus and the strength of its victims.

covid-19

covid-19 infection

covid-19 2025 variant

longest covid infection

persistent covid case

new covid mutation

uk covid study

covid in immunocompromised

covid-19 latest news

Can you imagine testing positive for COVID-19 for more than 500 days- during lockdowns, vaccine distributions, new strains, and changing worldwide policies? It reads like the script of a dystopian thriller, but it's real and illustrates just how capricious this virus has proven to be, five years on from its initial outbreak.As we step through 2025 with vaccines out there in plenty, rapid testing business as usual, and public health measures optimized, it's hard not to consider COVID-19 a chapter we're finally closing. But for a number of people, the virus wasn't an ordeal that lasted for a matter of weeks, but a long, persistent fight. One such example in the United Kingdom beat all known records: a man was infected with the virus for an incredible 505 days before his death, which stands as the longest confirmed COVID-19 infection to date.British researchers have found what seems to be the longest-reported COVID-19 infection to date, an astonishing 505 days. The case of the unnamed patient with several chronic health conditions and a very compromised immune system highlights the nuance of how SARS-CoV-2 acts in immunocompromised patients.The patient, who had tested positive for COVID-19 early in the year 2020, was infected for the rest of their life until they passed away in 2021 despite treatment interventions such as antiviral medication. This case has redefined what the global medical community knows about persistent COVID-19 infections and presented new avenues for research and better care for at-risk populations.What Makes This Case And Persistent COVID-19 Different?One of the most important differences to grasp is between "persistent" infection from COVID-19 and "Long COVID." While Long COVID is a term used for symptoms that persist after the virus has cleared from the body, persistent infection involves ongoing viral replication over time. The virus in this instance never actually leaves the body, which forms ongoing active infection instead of residual symptoms.In this British case, all of the patient's over 50 PCR tests in 72 weeks returned positive, indicating a persistent, constant infection. This was reinforced by King's College London and Guy's and St Thomas' NHS Foundation Trust researchers through genomic sequencing that indicated it was the same strain evolving over time—not repeated reinfections.This unusual case was one of many included in a larger study that was discussed at the European Congress of Clinical Microbiology and Infectious Diseases by infectious disease specialist Dr. Luke Blagdon Snell. The study looked at nine patients with long-term infections, all lasting at least eight weeks. These patients, whose immune systems were severely impaired due to illness such as HIV, cancer, or immunosuppressive drugs used after organ transplant, provided an unusual insight into what happens when the body is unable to respond with a normal immune response.The typical length of infection in the nine patients was about 73 days. Prior to the identification of this record case, the longest-documented COVID-19 infection was 335 days long.What are Persistent Infections?While unusual, these long-term infections create worries beyond the patients themselves. One of the scientists' biggest worries is that the virus, not having been contained by the body for so long, could mutate into new strains. Though none of the patients in this case—including one who had a 505-day infection—gave rise to a new variant of concern, genetic analysis did reveal mutations like those that occur in highly circulated variants."This doesn't say anything about a single patient. It says something about how the virus might evolve over time if left in a setting in which it's not eliminated," Dr. Snell stated.Even after receiving antiviral medications such as remdesivir, the patient could not eliminate the infection, showing the insufficiency of existing treatments in certain high-risk groups. Among the nine patients analyzed, five survived with different recovery trajectories. Two cleared the virus without any medication, two were responsive to antiviral treatment, and one patient remained infected after 412 days at the last reported follow-up.This unsettling volatility identifies the imperative for greater treatment options and care customization for immunocompromised individuals.What This Means for People With Low Immunity?Tens of millions of individuals across the globe have weakened immune systems—because of organ transplants, autoimmune conditions, or cancer treatments. The results from this study indicate an immediate call to maintain awareness in safeguarding these groups, particularly as pandemic measures loosened and mask mandates are all but gone.This case not only illuminates the biological dynamics of COVID-19 but also serves as a reminder of the human narratives behind pandemic statistics. This patient existed, in a state of health most people shake off in a matter of days or weeks, for almost a year and a half—a grim reminder of the unpredictability of the virus and the strength of its victims.

longest covid infection reported lasted 505 days nonstop; what are persistent infections?

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Influenza Raises Heart Attack Risk By 6X– Here's Another Reason To Get Your Flu Shot

Quick Stories

COVID Cases Rise In US, Trump Administration To Alter Vaccine Policy

Rise In Drug-Related Deaths Blamed For Increase In UK Mortality Rate

Longest Covid Infection Reported Lasted 505 Days Nonstop; What Are Persistent Infections?

Health Conditions A-Z

COVID Cases Rise In US, Trump Administration To Alter Vaccine Policy

Rise In Drug-Related Deaths Blamed For Increase In UK Mortality Rate

About 2 Out Of 5 Heart Failure Patients Don’t See A Cardiologist Even Once A Year